These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6248174)

  • 21. Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing.
    Fallon JH; Leslie FM; Cone RI
    Neuropeptides; 1985 Feb; 5(4-6):457-60. PubMed ID: 2860605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology?
    Heim C; Sova L; Kurz T; Kolasiewicz W; Schwegler H; Sontag KH
    J Neural Transm (Vienna); 2002 May; 109(5-6):691-709. PubMed ID: 12111461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of disulphide and sulphydryl groups in clustering of enkephalin receptors in neuroblastoma cells.
    Hazum E; Chang KJ; Cuatrecasas P
    Nature; 1979 Dec; 282(5739):626-8. PubMed ID: 233139
    [No Abstract]   [Full Text] [Related]  

  • 24. Search for the presence of glucocorticoid receptors in dopaminergic neurons of rat ventral tegmental area and substantia nigra.
    Czyrak A; Chocyk A
    Pol J Pharmacol; 2001; 53(6):681-4. PubMed ID: 11985346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-binding proteins in the substantia nigra and ventral tegmental area during development: correlation with dopaminergic compartmentalization.
    Alfahel-Kakunda A; Silverman WF
    Brain Res Dev Brain Res; 1997 Oct; 103(1):9-20. PubMed ID: 9370056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine.
    Daugé V; Kalivas PW; Duffy T; Roques BP
    Brain Res; 1992 Dec; 599(2):209-14. PubMed ID: 1291031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and subacute effects of haloperidol on dopac levels in the substantia nigra and ventral tegmental area of rat brain.
    Scatton B
    Eur J Pharmacol; 1979 Jun; 56(1-2):183-4. PubMed ID: 467510
    [No Abstract]   [Full Text] [Related]  

  • 28. Enkephalin-immunoreactive cells in the mesencephalic tegmentum project to the optic tectum of the teleosts Salmo gairdneri and Salmo salar.
    Vecino E; Ekström P; Sharma SC
    Cell Tissue Res; 1991 Apr; 264(1):133-7. PubMed ID: 1905200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical evidence for direct connections between neurotensin-containing axons and dopaminergic neurons in the rat ventral midbrain tegmentum.
    Woulfe J; Beaudet A
    Brain Res; 1989 Feb; 479(2):402-6. PubMed ID: 2564307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the mesocortical dopaminergic system involved in Parkinson disease?
    Javoy-Agid F; Agid Y
    Neurology; 1980 Dec; 30(12):1326-30. PubMed ID: 6109265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phencyclidine suppresses the activity of midbrain dopamine-containing neurons recorded from mouse brain slices in vitro.
    Trulson ME; Arasteh K
    Eur J Pharmacol; 1987 Jan; 133(3):345-9. PubMed ID: 3556396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine- and cholecystokinin-containing neurons of the crossed mesostriatal projection.
    Fallon JH; Wang C; Kim Y; Canepa N; Loughlin S; Seroogy K
    Neurosci Lett; 1983 Oct; 40(3):233-8. PubMed ID: 6316210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical mapping of enkephalin containing cell bodies, fibers and nerve terminals in the brain stem of the rat.
    Uhl GR; Goodman RR; Kuhar MJ; Childers SR; Snyder SH
    Brain Res; 1979 Apr; 166(1):75-94. PubMed ID: 217503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum.
    Fallon JH; Moore RY
    J Comp Neurol; 1978 Aug; 180(3):545-80. PubMed ID: 659674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of haloperidol on DOPAC levels in the substantia nigra and ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Gessa GL
    Pharmacol Res Commun; 1980 Jul; 12(7):683-8. PubMed ID: 7403237
    [No Abstract]   [Full Text] [Related]  

  • 36. Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Gessa GL
    Life Sci; 1979 Jun; 24(24):2279-84. PubMed ID: 502748
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
    Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
    Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
    [No Abstract]   [Full Text] [Related]  

  • 39. The organization of dopaminergic and non-dopaminergic mesencephalo-cortical neurons in the rat.
    Albanese A; Bentivoglio M
    Brain Res; 1982 Apr; 238(2):421-5. PubMed ID: 7093662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous enkephalin modulation of dopamine neurons in ventral tegmental area.
    Kalivas PW; Richardson-Carlson R
    Am J Physiol; 1986 Aug; 251(2 Pt 2):R243-9. PubMed ID: 3017134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.